Medline Inc. (MDLN) stock

MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3066% above fair value

$39.47−0.51 (-1.28%)

Close on Nov 13, 2026Market cap $51.89BP/E –Yield –

Medline enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Medline has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MDLN.

Gross margin25.7% · median 54.8%

Operating margin5.7% · median 10.7%

Net margin3.8% · median 3.0%

Advertisement
300 × 250

See a number that looks wrong?